Related Experiment Video

Updated: Feb 18, 2026

RhoC GTPase Activation Assay
09:58

RhoC GTPase Activation Assay

Published on: August 22, 2010

13.1K

The Rho GTPase signalling pathway in urothelial carcinoma

Solomon L Woldu1, Ryan C Hutchinson1, Laura-Maria Krabbe1

  • 1University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390-9110, USA.

Nature Reviews. Urology
|November 15, 2017
PubMed

Insights

Urothelial carcinoma poses treatment challenges. Rho GTPase signaling pathways are implicated in this cancer and may offer future therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Urothelial carcinoma presents significant clinical challenges, with high recurrence rates for non-muscle-invasive disease and poor outcomes for advanced stages due to limited systemic therapies.
  • The Rho GTPase family, comprising over 20 enzymes, plays crucial roles in fundamental cellular processes like migration, polarity, adhesion, cell cycle, and cytoskeleton regulation.

Purpose of the Study:

  • To explore the role of Rho GTPase signaling pathways in urothelial carcinoma.
  • To investigate the potential of targeting Rho GTPase pathways for therapeutic intervention in urothelial carcinoma.

Main Methods:

  • Review of existing literature on Rho GTPase function and their implication in malignancies.
  • Analysis of the current understanding of Rho GTPase aberrations in urothelial carcinoma.

Main Results:

  • Rho GTPases function as molecular switches, cycling between inactive (GDP-bound) and active (GTP-bound) states.
  • Aberrations in Rho GTPase signaling pathways are increasingly linked to various cancers, including urothelial carcinoma.

Conclusions:

  • The Rho GTPase signaling pathway is a promising area for therapeutic targeting in urothelial carcinoma.
  • Current research is in its early stages, requiring further investigation to translate laboratory findings into clinical applications.

Related Concept Videos

Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
5.5K
GTPases and their Regulation02:14

GTPases and their Regulation

Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒  small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins,...
9.9K
GTPases and their Regulation02:14

GTPases and their Regulation

3.0K
Activation and Inactivation of G Proteins01:22

Activation and Inactivation of G Proteins

Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
11.8K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.4K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
18.7K